FDA Inspection 1118644 — Granules India Limited

Granules India Limited — FEI 3004097901

The FDA completed an inspection of Granules India Limited on February 14, 2020 in Medchal-Malkhajgiri District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal-Malkhajgiri District (India)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
202721 CFR 211.192Investigations of discrepancies, failures